SCHEMBL22952992

SCHEMBL22952992

Oc1ccc2c(c1O)CC(c1ccnc(Br)c1)C1CCNCC21

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DRD1 P21728 4/20 0.65
DRD2 P14416 3/20 0.65
ADRA2A P08913 1/20 0.65
ADRA2B P18089 1/20 0.65
ADRA2C P18825 1/20 0.65
DRD5 P21918 1/20 0.65
DRD3 P35462 1/20 0.65
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
LMNA P02545 1/20 0.30
ESR1 P03372 1/20 0.30
GAA P10253 1/20 0.30
MAPT P10636 1/20 0.30
G6PD P11413 1/20 0.30
PKM P14618 1/20 0.30
MAPK1 P28482 1/20 0.30
MPI P34949 1/20 0.30
KMT2A Q03164 1/20 0.30
ESR2 Q92731 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22952932 0.89 ADRA2A (0.68) DRD1DRD2ADRA2AADRA2BADRA2C
SCHEMBL22952936 0.88 DRD1 (0.63) DRD1DRD2ADRA2AADRA2BADRA2C
SCHEMBL22953002 0.87 ADRA2A (0.65) DRD1DRD2ADRA2AADRA2BADRA2C
SCHEMBL22952996 0.87 DRD1 (0.65) DRD1DRD2ADRA2AADRA2BADRA2C
SCHEMBL22952994 0.87 ADRA2A (0.65) DRD1DRD2ADRA2AADRA2BADRA2C
SCHEMBL22952993 0.85 ADRA2A (0.62) DRD1DRD2ADRA2AADRA2BADRA2C
SCHEMBL22952930 0.84 ADRA2A (0.78) DRD1DRD2ADRA2AADRA2BADRA2C
SCHEMBL611683 0.79 DRD1 (1.00) DRD1DRD2ADRA2AADRA2BADRA2C
SCHEMBL22953352 0.79 ADRA2A (0.44) DRD1DRD2ADRA2AADRA2BADRA2C
SCHEMBL22953003 0.78 ADRA2A (0.45) DRD1DRD2ADRA2AADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021021922-A1 COMPOUNDS AND METHODS FOR TREATING FIBROTIC PATHOLOGIES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2021-02-04 WO disclosed